Response to: Ranibizumab vs. pegaptanib: a cost-effectiveness study? [PDF]
Luis Javier Hernández-Pastor
openalex +1 more source
Neovascular glaucoma: comprehensive evaluation of etiology, treatment modalities, and visual prognosis. [PDF]
Gerçeker Demircan S, Şanal Doğan A.
europepmc +1 more source
Ranibizumab (Lucentis®) intravítreo en el tratamiento de membrana neovascular coroidea secundaria a coroidopatía punctata interna [PDF]
A. Valverde-Megías +5 more
openalex +1 more source
Efficacy of Intravitreal Conbercept in Vitrectomy for Proliferative Diabetic Retinopathy: An Integrated Meta-Analysis and Bibliometric Study. [PDF]
Li G +8 more
europepmc +1 more source
Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab [PDF]
Carsten H. Meyer, Frank G. Holz
openalex +1 more source
Real world outcomes of faricimab in treatment resistant neovascular age-related macular degeneration among Asian patients. [PDF]
Neo EZO +17 more
europepmc +1 more source
Effect of Faricimab on Visual Acuity and Retinal Structure in Neovascular Age-Related Macular Degeneration Previously Treated With Anti-VEGF Therapy. [PDF]
Sattah N +10 more
europepmc +1 more source
RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION [PDF]
Joseph M. Googe +11 more
openalex +1 more source
The SDF-1α/MTDH axis inhibits ferroptosis and promotes the formation of anti-VEGF-resistant choroidal neovascularization by facilitating the nuclear translocation of SREBP1. [PDF]
Zou R +5 more
europepmc +1 more source

